How best to treat each patient with Parkinson’s disease? That is the key challenge facing many neurologists, and something which changes with each new insight into the disease, its progression, and the expanding treatment arsenal.
As a prelude to an exciting Virtual Symposium on the latest and best treatments in personalised medicine for Parkinson’s disease, global leader Prof. Dr Heinz Reichmann discusses why we need personalised medicine, how it improves patient quality of life, and the more effective treatments currently available.
The Virtual Symposium itself will take place at the MDS 2021 Virtual Meeting (17–22 September 2021). It will be Chaired by Prof. Dr Reichmann, and will include several presentations from world leaders in the field:
How to tailor the treatment in PD patients after L-dopa “honeymoon”?
Prof. J. Pagonabarraga of the University of Barcelona, Spain
QoL of PD patients: the influence of the motor fluctuations and non-motor symptoms
Prof. A. Antonini of the University of Padua, Italy
Influence of age and comorbidities on treatment of motor fluctuations: real world evidence data
Prof. W. Jost of the University of Freiburg, Germany.
This will be followed by a roundtable discussion involving the whole faculty.
Please visit the MDS site to sign up for this exciting opportunity to explore the latest insights into the management of Parkinson’s disease.
Prof. Dr Heinz Reichmann discloses: Honoraria for lectures and advice from Bial, UCB, and Zambon.
This content is intended for healthcare professionals only and has been sponsored by Zambon SpA. Zambon SpA provided financial support and has had input into the selection of the faculty and the detailed project scope. This content is provided by Touch Medical Communications (TMC) for touchNEUROLOGY.
Launch date: September 2021
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!